IRadimed Corporation
IRMD | NASDAQ
$83.11
+$0.65 (+0.79%)
Sep 22, 2026, 11:07 AM ET · Market open
Market Data
Market Cap $1.05B
Enterprise Value $995.01M
Beta 0.90
Average Volume 132.63K
Shares Outstanding (Diluted) 12.87M
Shares Change YoY 0.32%
Institutional Ownership 59.68%
Exchange NASDAQ
ISIN US46266A1097
Price Performance
Price Change 1M -6.4%
Price Change 3M -10.7%
Price Change 6M -19.0%
Price Change YTD -13.7%
Price Change 1Y 16.6%
Price Change 3Y 89.7%
Price Change 5Y 141.2%
1M CAGR (ann.) -10.6%
1Y CAGR (ann.) 15.5%
5Y CAGR (ann.) 21.2%
All-Time CAGR 19.9%
Valuation
PE Ratio 46.07
Forward PE 34.06
PEG Ratio 3.89
Forward PEG 2.96
PS Ratio 12.21
Forward PS 10.40
PB Ratio 10.36
P/FCF Ratio 42.28
P/Adj. FCF Ratio 46.35
P/OCF Ratio 38.90
EV/Sales 11.52
EV/EBIT 43.53
EV/EBITDA 32.41
EV/FCF 39.91
Earnings Yield 2.2%
FCF Yield 2.4%
Adj. FCF Yield 2.2%
Financial Health
Net Cash $59.08M
Total Debt $0
Cash & Short-Term Investments $59.08M
Total Assets $114.98M
Current Ratio 9.46
Quick Ratio 8.13
Debt / Equity Ratio 0.00
Debt / EBITDA 0.00
Debt / FCF 0.00
OCF / Debt N/A
Interest Coverage 0.00
Altman Z-Score 50.89
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 75.9%
Operating Profit Margin 31.9%
EBITDA Margin 36.0%
Net Profit Margin 26.7%
FCF Margin 28.9%
Adj. FCF Margin 26.3%
SBC / Revenue 2.5%
SBC Impact (per share) -8.8%
Returns
Return on Assets 20.1%
Return on Equity 23.4%
Return on Invested Capital 20.2%
Return on Capital Employed 26.0%
Return on Tangible Assets 20.7%
Historical Growth (CAGR)
Revenue CAGR 3Y 13.0%
Revenue CAGR 5Y 19.6%
Revenue CAGR 10Y 9.2%
EPS CAGR 3Y 15.6%
EPS CAGR 5Y 37.1%
EPS CAGR 10Y 9.5%
FCF CAGR 3Y 51.5%
FCF CAGR 5Y 26.2%
FCF CAGR 10Y 12.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 2
EPS Growth Next 3Y 18.9%
Revenue Growth Next 3Y 15.2%
Earnings Date Nov 1, 2026
EPS Estimate (next Q) $0.52
EPS Growth Est (next Q) 10.6%
Revenue Est (next Q) $23.2M
Revenue Growth Est (next Q) 9.4%
Fair Value Estimates
Graham Number $17.90
Graham Upside -78.3%
Lynch Fair Value $44.75
Lynch Upside -45.7%
Price Target $100
Price Target Upside 21.3%
Cash Flow
Operating Cash Flow $27.14M
Free Cash Flow $24.93M
Adj. Free Cash Flow $22.74M
FCF Per Share $1.95
OCF Per Share $2.12
OCF/S Ratio 31.4%
Income Statement
Revenue $86.34M
Gross Profit $65.5M
Operating Income $27.55M
EBITDA $30.7M
Net Income $23.05M
EPS (Diluted) $1.79
Revenue / Employee $520.11K
Profit / Employee $138.88K
Employees 166
Dividends
Annual Dividend $1.10
Dividend Yield 1.33%
Payout Ratio 61.5%
FCF Payout Ratio 63.5%
Adj. FCF Payout Ratio 69.6%
Dividend Growth (YoY) 61.8%
Pay Frequency Quarterly
Ex-Dividend Date Aug 13, 2026
Add to Watchlist
Select watchlists to add or remove IRMD